Lipocine Inc reports results for the quarter ended in June - Earnings Summary

Lipocine

08/08/2022 14:32

* Lipocine Inc  LPCN.OQ  reported a quarterly adjusted loss
of 3
cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 4 cents per share.
    * Revenue was $500.00 thousand​; analysts expected $257.00
thousand. 
    * Lipocine Inc's reported EPS for the quarter was a loss
of 3
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lipocine Inc shares had risen by 2.7% this quarter and
lost 17.0% so far this year.
    * The company reported a quarterly loss of $2.63 million.
    * Wall Street's median 12-month price target for Lipocine
Inc is
$3.25 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 8
at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.04          -0.03          Beat
 Mar. 31 2022      -0.02          -0.04          Missed
 Dec. 31 2021      -0.01          0.15           Beat
 Sep. 30 2021      -0.04          -0.03          Beat